DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bxvkpw/global_nebulizer) has announced the addition of the "Global Nebulizer Market 2011-2015" report to their offering.
TechNavio's analysts forecast the Global Nebulizer market to grow at a CAGR of 5.1 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in the incidence of lung-related or respiratory diseases. The Global Nebulizer market has also been witnessing the trend of the increasing adoption of online marketing strategy. However, the availability of other types of inhalers in the market could pose a challenge to the growth of this market.
The key vendors dominating this market space are Allied Healthcare Product Inc., GF health Product Inc., Omron Healthcare Co. Ltd., PARI Respiratory Equipment Inc., and Philips Respironics Inc.
The other vendors mentioned in the report are Drive Medical Design and Manufacturing and MABIS Healthcare Inc.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Vendors are increasing their online marketing and promotional activities to increase the sales and reach of their products. This not only provides customers with easy access, but it also helps vendors reduce their setup, distribution and operational costs. A large number of small and big vendors sell nebulizers and their consumables online. Furthermore, there are no time limitations in buying from online websites as opposed to medical stores. The increasing adoption of an online marketing strategy is increasing the sales of nebulizers, thereby helping the market grow.''
According to the report, one of the main drivers is the increasing incidence of lung-related or respiratory diseases. These diseases represent a challenge to the public health in both developed and developing countries. The key reasons for the increasing incidence of these diseases are an increase in global population, sedentary lifestyles, smoking, and environmental pollution.
Further, the report reveals that one of the main market challenges is the availability of other types of inhalers for the treatment of respiratory diseases.
For more information visit http://www.researchandmarkets.com/research/bxvkpw/global_nebulizer